Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$13.58 - $17.36 $176 - $225
13 Added 185.71%
20 $0
Q4 2023

Feb 09, 2024

SELL
$10.11 - $16.54 $30 - $49
-3 Reduced 30.0%
7 $0
Q3 2023

Nov 13, 2023

BUY
$12.46 - $15.48 $37 - $46
3 Added 42.86%
10 $0
Q4 2022

Feb 13, 2023

BUY
$14.85 - $19.04 $103 - $133
7 New
7 $0
Q1 2022

May 13, 2022

SELL
$6.87 - $11.11 $96 - $155
-14 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$7.7 - $37.13 $107 - $519
14 New
14 $0

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.